Skip to main content
. 2007 Feb;23(2):125–131. doi: 10.1016/s0828-282x(07)70732-8

Figure 2).

Figure 2)

The Adenomatous Polyp PRevention On Vioxx (APPROVe) trial (6). Kaplan-Meier estimates of the cumulative incidence of confirmed serious thrombotic events. Vertical lines indicate 95% CI. Reproduced from reference 6 with permission